Jessica Mega, MD;MPH

South San Francisco, California, United States
Jessica L. Mega, MD, MPH, is the Co-Founder and Chief Medical and Scientific Officer
at Verily. As CMSO, Dr. Mega's focus is on translating technological innovations and
scientific insights into partnerships and programs that improve patient outcomes and
healthcare. She oversees all of Verily's clinical and science efforts.
As a faculty member at Harvard Medical School, a senior investigator with the TIMI
Study Group, and a cardiologist at Brigham and Women’s Hospital, she led large,
international, randomized trials evaluating novel cardiovascular therapies. She also
directed the TIMI Study Group’s Genetics Program. Her findings have been published in
the New England Journal of Medicine, Lancet, JAMA, and elsewhere. She has served
on the Advisory Group for the California Governor’s Precision Medicine work. Dr. Mega
currently sits on the Advisory Board for the Duke-Margolis Center for Health Policy and
Research!America, as well as the Board of Directors for Danaher Corporation.
Dr. Mega is a graduate of Stanford University, Yale University School of Medicine, and
Harvard School of Public Health. She completed Internal Medicine Residency at
Brigham and Women’s Hospital and Cardiovascular Fellowship at Massachusetts
General Hospital. She is board certified in Internal Medicine and Cardiology. She has
won the Laennec Society, Samuel A. Levine, and Douglas P. Zipes Awards, and she is
a Fellow of the American Heart Association (AHA) and the American College of
Cardiology (ACC).
Speaking In
1:45 PM - 2:45 PM (PDT)
Tuesday, June 14
Jessica L. Mega, MD, MPH, is the Chief Medical and Scientific Officer at Verily. As CMSO, Dr. Mega…